Meeting
2021 ASCO Annual Meeting
Validation of the RSClin risk calculator using the National Cancer Database (NCDB).
Authors
Frederick Howard
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Frederick Howard , Alexander T. Pearson , Rita Nanda , Olufunmilayo I. Olopade , Dezheng Huo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 549)
DOI
10.1200/JCO.2021.39.15_suppl.549
Abstract #
549
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Treatment outcomes in patients with discordant recurrence score and RSClin risk predictions.
First Author: Augustin Vannier
Poster
2021 ASCO Quality Care Symposium
Characterizing attitudes related to child-bearing in young women diagnosed with early breast cancer (EBC).
First Author: Saumya Umashankar
First Author: Oleg Gluz
Poster
2020 ASCO Virtual Scientific Program
Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland.
First Author: Lynda M McSorley